Mark L. Lang

1.6k total citations
63 papers, 1.2k citations indexed

About

Mark L. Lang is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mark L. Lang has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 18 papers in Molecular Biology and 14 papers in Infectious Diseases. Recurrent topics in Mark L. Lang's work include Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (21 papers) and Clostridium difficile and Clostridium perfringens research (12 papers). Mark L. Lang is often cited by papers focused on Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (21 papers) and Clostridium difficile and Clostridium perfringens research (12 papers). Mark L. Lang collaborates with scholars based in United States, United Kingdom and Switzerland. Mark L. Lang's co-authors include Gillian A. Lang, William F. Wade, Li Shen, Sunil K. Joshi, Michael A. Kerr, Mark A. Exley, Jimmy D. Ballard, Noah S. Butler, Martin J. Richer and Gurdyal S. Besra and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark L. Lang

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Lang United States 20 794 280 213 177 144 63 1.2k
Jacinto López‐Sagaseta Spain 16 483 0.6× 282 1.0× 113 0.5× 118 0.7× 137 1.0× 25 1.0k
Zu T. Shen United States 12 826 1.0× 396 1.4× 124 0.6× 179 1.0× 249 1.7× 16 1.2k
Karen Duus United States 22 545 0.7× 284 1.0× 229 1.1× 225 1.3× 348 2.4× 34 1.3k
Fazel Shokri Iran 21 611 0.8× 406 1.4× 218 1.0× 45 0.3× 145 1.0× 74 1.2k
Isabelle Magalhaes Sweden 22 590 0.7× 296 1.1× 410 1.9× 210 1.2× 256 1.8× 52 1.2k
Adriana Baz Morelli Australia 18 536 0.7× 302 1.1× 88 0.4× 149 0.8× 161 1.1× 31 1.0k
Ragnar Lindstedt Italy 21 567 0.7× 399 1.4× 96 0.5× 71 0.4× 167 1.2× 28 1.3k
Agnes E. Hamburger United States 13 262 0.3× 287 1.0× 156 0.7× 108 0.6× 115 0.8× 19 769
S Badrinath India 18 779 1.0× 375 1.3× 422 2.0× 72 0.4× 211 1.5× 48 1.5k
Roberto De Pascalis United States 18 721 0.9× 531 1.9× 445 2.1× 230 1.3× 108 0.8× 32 1.4k

Countries citing papers authored by Mark L. Lang

Since Specialization
Citations

This map shows the geographic impact of Mark L. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Lang more than expected).

Fields of papers citing papers by Mark L. Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Lang. The network helps show where Mark L. Lang may publish in the future.

Co-authorship network of co-authors of Mark L. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Lang. A scholar is included among the top collaborators of Mark L. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Lang. Mark L. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Gillian A., et al.. (2025). Protocol to measure the impact of Clostridioides difficile toxins on antibody responses using ELISA, ELISPOT, and toxin-neutralization assays. STAR Protocols. 6(2). 103754–103754. 1 indexed citations
2.
Nofchissey, Robert A., Megan R. Lerner, Kar‐Ming Fung, et al.. (2023). G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer. Clinical Cancer Research. 29(11). 2158–2169. 5 indexed citations
3.
4.
Liu, Kai‐Li, Ashley R. Hoover, Xiao-Hong Sun, et al.. (2021). Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics. 12(2). 639–656. 12 indexed citations
5.
Smith, Kenneth G. C., et al.. (2020). Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight. 5(16). 15 indexed citations
6.
Smith, Kenneth G. C., Jonathan D. Wren, Carol F. Webb, et al.. (2019). Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Frontiers in Immunology. 9. 3064–3064. 19 indexed citations
7.
Zhou, Feifan, Jingxuan Yang, Yuqing Zhang, et al.. (2018). Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine. Clinical Cancer Research. 24(21). 5335–5346. 81 indexed citations
8.
Joshi, Sunil K., et al.. (2011). CD40L-null NKT cells provide B cell help for specific antibody responses. Vaccine. 29(49). 9132–9136. 10 indexed citations
9.
Lang, Gillian A., et al.. (2011). Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory. International Immunology. 23(4). 251–260. 13 indexed citations
10.
Lang, Gillian A., et al.. (2010). CD1d-Dependent B-Cell Help by NK-Like T Cells Leads to Enhanced and Sustained Production of Bacillus anthracis Lethal Toxin-Neutralizing Antibodies. Infection and Immunity. 78(4). 1610–1617. 27 indexed citations
11.
Joshi, Sunil K., et al.. (2009). Bacillus anthracis Lethal Toxin Disrupts TCR Signaling in CD1d-Restricted NKT Cells Leading to Functional Anergy. PLoS Pathogens. 5(9). e1000588–e1000588. 30 indexed citations
12.
Lang, Gillian A., et al.. (2008). Glycolipid‐activated NKT cells support the induction of persistent plasma cell responses and antibody titers. European Journal of Immunology. 38(4). 1001–1011. 46 indexed citations
13.
Lang, Mark L., Roy A. Fava, Martin Grundy, et al.. (2007). A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling. Blood. 111(1). 344–350. 9 indexed citations
14.
Saban, Marcia R., Helen L. Hellmich, Cindy Simpson, et al.. (2007). Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer. 7(1). 204–204. 20 indexed citations
15.
Pleass, Richard J., Mark L. Lang, Michael A. Kerr, & Jenny M. Woof. (2006). IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Molecular Immunology. 44(6). 1401–1408. 33 indexed citations
16.
Lang, Gillian A., Petr A. Illarionov, Aharona Glatman‐Freedman, Gurdyal S. Besra, & Mark L. Lang. (2005). BCR targeting of biotin-α-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. International Immunology. 17(7). 899–908. 17 indexed citations
17.
Chen, Yih‐Wen, Mark L. Lang, & William F. Wade. (2004). Protein Kinase C‐α and ‐δ Are Required for FcαR (CD89) Trafficking to MHC Class II Compartments and FcαR‐Mediated Antigen Presentation. Traffic. 5(8). 577–594. 30 indexed citations
18.
19.
Lang, Mark L. & Michael A. Kerr. (2000). Characterization of FcαR-Triggered Ca2+ Signals: Role in Neutrophil NADPH Oxidase Activation. Biochemical and Biophysical Research Communications. 276(2). 749–755. 18 indexed citations
20.
Lang, Mark L., Li Shen, & William F. Wade. (1999). γ-Chain Dependent Recruitment of Tyrosine Kinases to Membrane Rafts by the Human IgA Receptor FcαR. The Journal of Immunology. 163(10). 5391–5398. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacinto López‐Sagaseta Breakdown of academic impact, for papers by Zu T. Shen Breakdown of academic impact, for papers by Karen Duus Breakdown of academic impact, for papers by Fazel Shokri Breakdown of academic impact, for papers by Isabelle Magalhaes Breakdown of academic impact, for papers by Adriana Baz Morelli Breakdown of academic impact, for papers by Ragnar Lindstedt Breakdown of academic impact, for papers by Agnes E. Hamburger Breakdown of academic impact, for papers by S Badrinath Breakdown of academic impact, for papers by Roberto De Pascalis
Rankless by CCL
2026